Cargando…

Cellular and Biophysical Pipeline for the Screening of Peroxisome Proliferator-Activated Receptor Beta/Delta Agonists: Avoiding False Positives

Peroxisome proliferator-activated receptor beta/delta (PPARß/δ) is considered a therapeutic target for metabolic disorders, cancer, and cardiovascular diseases. Here, we developed one pipeline for the screening of PPARß/δ agonists, which reduces the cost, time, and false-positive hits. The first ste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Videira, Natália Bernardi, Batista, Fernanda Aparecida Heleno, Torres Cordeiro, Artur, Figueira, Ana Carolina Migliorini
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924986/ https://www.ncbi.nlm.nih.gov/pubmed/29849537 http://dx.doi.org/10.1155/2018/3681590

Ejemplares similares

Structural Insights into Human Peroxisome Proliferator Activated Receptor Delta (PPAR-Delta) Selective Ligand Binding
por: Batista, Fernanda A. H., et al.
Publicado: (2012)

Peroxisome Proliferator-Activated Receptor Beta/Delta Agonist Suppresses Inflammation and Promotes Neovascularization
por: Tobita, Yutaro, et al.
Publicado: (2020)

Screening for PPAR Non-Agonist Ligands Followed by Characterization of a Hit, AM-879, with Additional No-Adipogenic and cdk5-Mediated Phosphorylation Inhibition Properties
por: Ribeiro Filho, Helder Veras, et al.
Publicado: (2018)

Gene Doping with Peroxisome-Proliferator-Activated Receptor Beta/Delta Agonists Alters Immunity but Exercise Training Mitigates the Detection of Effects in Blood Samples
por: Sibille, Brigitte, et al.
Publicado: (2021)

Avoiding false discovery in biomarker research
por: Patel, Pranali, et al.
Publicado: (2016)

Psychoactive drugs and false memory: comparison of dextroamphetamine and delta-9-tetrahydrocannabinol on false recognition
por: Ballard, Michael E., et al.
Publicado: (2011)

The selective peroxisome proliferator–activated receptor‐delta agonist seladelpar reverses nonalcoholic steatohepatitis pathology by abrogating lipotoxicity in diabetic obese mice
por: Haczeyni, Fahrettin, et al.
Publicado: (2017)

Automated Pipeline for Purification, Biophysical and X-Ray Analysis of Biomacromolecular Solutions
por: Graewert, Melissa A., et al.
Publicado: (2015)

Biophysical Screening Pipeline for Cryo-EM Grid Preparation of Membrane Proteins
por: Niebling, Stephan, et al.
Publicado: (2022)

PPARγ S273 Phosphorylation Modifies the Dynamics of Coregulator Proteins Recruitment
por: Dias, Marieli Mariano Gonçalves, et al.
Publicado: (2020)

PB2281: HOW TO AVOID FALSE-NEGATIVE AND FALSE-POSITIVE COVID-19 PCR TESTING
por: Fevraleva, I., et al.
Publicado: (2022)

Waiting time and the psychosocial consequences of false-positive mammography: cohort study
por: Heleno, Bruno, et al.
Publicado: (2015)

A Role for Peroxisome Proliferator-Activated Receptor Gamma Agonists in Counteracting the Degeneration of Cardiovascular Grafts
por: Assmann, Anna Kathrin, et al.
Publicado: (2022)

Solutions to Avoid False Positives for Rituximab in Pre-Transplant Crossmatches
por: Colmenero Velazquez, Argentina, et al.
Publicado: (2020)

The Renoprotective Actions of Peroxisome Proliferator-Activated Receptors Agonists in Diabetes
por: Thomas, M. C., et al.
Publicado: (2012)

The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis
por: Li, Jingjing, et al.
Publicado: (2021)

How to Avoid False-Negative and False-Positive Diagnoses of Platelet Apoptosis: Illustrative Experimental and Clinically Relevant Cases
por: Leytin, Valery, et al.
Publicado: (2018)

Comparative analysis of whole-genome sequencing pipelines to minimize false negative findings
por: Hwang, Kyu-Baek, et al.
Publicado: (2019)

Constant false alarm rate detection of pipeline leakage based on acoustic sensors
por: An, Guorui, et al.
Publicado: (2023)

VPBR: An Automatic and Low-Cost Vision-Based Biophysical Properties Recognition Pipeline for Pumpkin
por: Dang, L. Minh, et al.
Publicado: (2023)

Inducible Conditional Vascular-Specific Overexpression of Peroxisome Proliferator-Activated Receptor Beta/Delta Leads to Rapid Cardiac Hypertrophy
por: Wagner, Kay-Dietrich, et al.
Publicado: (2016)

Peroxisome Proliferator-Activated Receptor Agonists: Do They Increase Cardiovascular Risk?
por: Aljada, Ahmad, et al.
Publicado: (2009)

Repurposing Peroxisome Proliferator-Activated Receptor Agonists in Neurological and Psychiatric Disorders
por: Sagheddu, Claudia, et al.
Publicado: (2021)

Enhanced Hepatocarcinogenicity Due to Agonists of Peroxisome Proliferator-Activated Receptors in Senescent Rats: Role of Peroxisome Proliferation, Cell Proliferation, and Apoptosis
por: Youssef, Jihan, et al.
Publicado: (2002)

Environmental and socioeconomic impacts of pipeline transport interdiction in Niger Delta, Nigeria
por: Umar, H.A., et al.
Publicado: (2021)

Erratum to “Inducible Conditional Vascular-Specific Overexpression of Peroxisome Proliferator-Activated Receptor Beta/Delta Leads to Rapid Cardiac Hypertrophy”
por: Wagner, Kay-Dietrich, et al.
Publicado: (2018)

Haplotypes of the porcine peroxisome proliferator-activated receptor delta gene are associated with backfat thickness
por: Meidtner, Karina, et al.
Publicado: (2009)

Automated contouring and planning pipeline for hippocampal-avoidant whole-brain radiotherapy
por: Feng, Christine H., et al.
Publicado: (2020)

Pipelines and Systems for Threshold-Avoiding Quantification of LC–MS/MS Data
por: Sánchez Brotons, Alejandro, et al.
Publicado: (2021)

Exploration of beta-arrestin isoform signaling pathways in delta opioid receptor agonist-induced convulsions
por: Blaine, Arryn T., et al.
Publicado: (2022)

Suppression of Rat Oral Carcinogenesis by Agonists of Peroxisome Proliferator Activated Receptor γ
por: McCormick, David L., et al.
Publicado: (2015)

Synergy between peroxisome proliferator‐activated receptor γ agonist and radiotherapy in cancer
por: Huang, Guodong, et al.
Publicado: (2018)

Changes in the Biophysical Properties of the Cell Membrane Are Involved in the Response of Neurospora crassa to Staurosporine
por: Santos, Filipa C., et al.
Publicado: (2018)

Selective peroxisome proliferator-activated receptorα modulators (SPPARMα): The next generation of peroxisome proliferator-activated receptor α-agonists
por: Fruchart, Jean-Charles
Publicado: (2013)

Interaction between Calpain 5, Peroxisome proliferator-activated receptor-gamma and Peroxisome proliferator-activated receptor-delta genes: a polygenic approach to obesity
por: Sáez, María E, et al.
Publicado: (2008)

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
por: Syversen, Unni, et al.
Publicado: (2009)

A biophysical model of striatal microcircuits suggests gamma and beta oscillations interleaved at delta/theta frequencies mediate periodicity in motor control
por: Chartove, Julia A. K., et al.
Publicado: (2020)

Biophysical Fitness Landscape of the SARS-CoV-2 Delta Variant Receptor Binding Domain
por: Patrick, Casey, et al.
Publicado: (2022)

Avoiding false-positive signals with nuclease-vulnerable molecular beacons in single living cells
por: Chen, Antony K., et al.
Publicado: (2007)

Peroxisome proliferator-activated receptor-γ agonists and diabetes: Current evidence and future perspectives
por: Chiarelli, Francesco, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_5td10cslueghgqmb1clos7g3p4